Clinical pipelines deploying selective prediction under imbalance should adopt threshold-aligned uncertainty measures and class-stratified evaluation to reduce class-specific risk imbalance, supporting safer selective prediction under the evaluated conditions without silently excluding the most vulnerable patients.
W. Endrizzi, F. Ragni, R. Marchesi et al.· 0 citations
It was showed that current prognostic models incompletely capture the biological heterogeneity underlying CRLM recurrence, and dynamic biomarkers and treatment-response indicators may support future multimodal prognostic frameworks and improve risk stratification following curative-intent treatment.
L. Manganaro, Tommaso Russo, L. Novello et al.· Critical reviews in oncology...· 0 citations
Overall, AI research in neurodegenerative diseases suffers from significant limitations in reproducibility, data inclusivity, and clinical translatability, and a set of recommendations can be adopted to address these issues and improve reliability and downstream clinical utility.
W. Endrizzi, F. Ragni, S. Bovo et al.· Communications Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.